Malaysia
Search
Sign In
Change Password
Points
Sign Out
Multidisciplinary
Top Medical News
Exposure to secondhand smoke seems to increase the risk of developing kidney stone disease, a recent study has found.
Infants born to mothers who were inactive during pregnancy were more likely to have low lung function compared with those whose mothers were active while pregnant, according to the PreventADALL study presented at ERS 2021.
SARS-CoV-2 has evolved in a way that makes the virus more capable at spreading, shunning antibodies, or both. What is more is that this change appears to be favouring a more efficient viral aerosol generation, as shown in a recent study.
Consumption of unprocessed red meat and poultry does not predict mortality or major cardiovascular disease (CVD), but a higher intake of processed meat is a risk factor for increased mortality and major CVD, according to the results of a large multinational prospective study.
Changes in sensor-derived behavioural features using a smartphone are associated with subsequent changes in mental health symptoms among people with elevated symptoms of depression, but there appears to be no evidence that depression changes correlate with subsequent changes in sensed behaviours, according to a study.
Advisers to the US FDA* unanimously voted for emergency use authorization (EUA) of the Pfizer/BioNTech COVID-19 vaccine booster dose in people 65 years and older and those at high risk of severe COVID-19.
A healthy diet, defined by adherence to either the Mediterranean diet, the World Health Organization (WHO) guidelines, or Dutch Health Council dietary guidelines, is predictive of better cognitive function and slower cognitive decline with ageing from middle age onward, a study has shown.
Special Reports
The FreeStyle Libre™
flash glucose monitoring system includes a sensor which automatically measures
and continuously stores up to 8 ours of glucose readings, allowing patients to
monitor their glucose levels without the need for painful finger pricks.
Physicians play an important role in reviewing and analysing glucose data that
is available through LibreView to support patient management.
At the recent EMPIRE (Evidence on the Management Pathway In T2D with CVD Risk and REnal Impairment) Summit organised by Boehringer Ingelheim, several eminent speakers shared the latest updates on T2D management and the need for early treatment intensification to optimise patient outcomes.
At the recent Malaysian Myeloproliferative Neoplasms (MPN) Expert Forum, Professor Martin Griesshammer from the Johannes Wesling University Hospital in Germany highlighted the role of personalised clinical decision-making tools and treatment in early-stage myelofibrosis. Chaired by Dr Alan Teh, Consultant Haematologist at Subang Jaya Medical Centre, the virtual forum was organised by Novartis, in collaboration with the Malaysian Society of Haematology (MSH).
Technological advancements have improved glucose
monitoring and diabetes care, as well as empowered patients in self-care. The
introduction of continuous glucose monitoring systems (CGM), such as the
Abbott FreeStyle LibreTM, offers patients an alternative and
additional advantages to self-monitoring of blood glucose (SMBG).
DKD is the principal cause of ESRD and remains one of the most prevalent complications among patients with T2DM.Hyperglycaemia is the main factor in the development and progression of DKD; once established, it triggers multiple pathogenic processes (eg, hypertension, altered tubuloglomerular feedback, renal hypoxia, lipotoxicity, inflammation), leading to a progressive decline in GFR.
At the recent Malaysia Myeloproliferative Neoplasms (MPN) Expert Forum webinar, Associate Professor Dr Haifa Kathrin Al-Ali, Senior Consultant of Haematology and Oncology and the head of the Krukenberg Cancer Center, University Hospital of Halle (Saale), Germany, presented the case for earlier treatment of myelofibrosis (MF) and better symptom management. The webinar was organized by Novartis in collaboration with the Malaysian Society of Haematology (MSH), and chaired by Dr Chew Lee Ping, Consultant Haematologist from Hospital Umum Sarawak.
During the EMPIRE Summit sponsored by Boehringer Ingelheim, two distinguished speakers shared their insights into the evolving treatment landscape of DKD. Topics discussed include the role of SGLT-2iin fulfilling the unmet needs in DKD management and how evidence of their cardio renal-protective effects have altered clinical practice guidelines globally.
Conference Reports
Infants born to mothers who were inactive during pregnancy were more likely to have low lung function compared with those whose mothers were active while pregnant, according to the PreventADALL study presented at ERS 2021.
The use of inhaled colistimethate sodium (CMS) via the I-neb was associated with a significantly reduced exacerbation rate among patients with bronchiectasis and chronic P. aeruginosa infection, according to the PROMIS-1* study presented at ERS 2021.
Swapping regular salt for a reduced-sodium salt substitute may cut stroke, major adverse cardiovascular event (MACE)*, and death rates in individuals with a risk of stroke, according to results of the SSaSS** trial.
A quadruple combination containing quarter doses of four blood pressure (BP)-lowering drugs in a single pill — termed a quadpill — led to better BP control than using monotherapy for initial treatment of hypertension, according to the QUARTET study presented at ESC 2021.
Receiving an influenza vaccination after hospitalization for an invasive coronary procedure or a myocardial infarction (MI) may reduce the risk of all-cause or cardiovascular (CV) death, according to results of the IAMI* trial.
Alcohol consumption during late adolescence and early adulthood was associated with increased arterial stiffness, which may lead to future cardiovascular events, according to a study presented at ESC 2021.
The combination of lenvatinib and pembrolizumab improved progression-free survival (PFS) and overall survival (OS) compared with physician’s choice of treatment (TPC) among patients with advanced endometrial cancer with prior exposure to platinum-based therapy, regardless of DNA mismatch repair (MMR) status, according to results of a phase III study presented at IGCS 2021.
Multimedia
